These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7992372)

  • 1. Reduction of donor-specific cytotoxic T lymphocyte precursors in peripheral blood of allografted heart recipients.
    Hu H; Robertus M; de Jonge N; Gmelig-Meyling FH; van der Meulen A; Schuurman HJ; Doornewaard H; van Prooijen HC; de Weger RA
    Transplantation; 1994 Dec; 58(11):1263-8. PubMed ID: 7992372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency analysis of donor-reactive cytotoxic T lymphocyte precursors in in allograft recipients. Lack of correlation with clinical outcome.
    Eberspächer ML; Otto G; Herfarth C; Kabelitz D
    Transplantation; 1994 Jun; 57(12):1746-52. PubMed ID: 8016880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No predictive value of cytotoxic or helper T-cell precursor frequencies for outcome when analyzed from the graft after stem cell transplantation.
    Kircher B; Niederwieser D; Gächter A; Lätzer K; Eibl G; Gastl G; Nachbaur D
    Ann Hematol; 2004 Sep; 83(9):566-72. PubMed ID: 15170521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-specific hyporeactivity after liver transplantation: prominent decreases in donor-specific cytotoxic T lymphocyte precursor frequencies independent of changes in helper T lymphocyte precursor frequencies or suppressor cell activity.
    de Haan A; van den Berg AP; Hepkema BG; van Dijk E; Haagsma EB; The TH; Slooff MJ; Lems SP; de Leij LF; Prop J
    Transplantation; 1998 Aug; 66(4):516-22. PubMed ID: 9734497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased donor-specific cytotoxic T cell precursor frequencies one year after clinical lung transplantation do not reflect transplantation tolerance: a comparison of lung transplant recipients with or without bronchiolitis obliterans syndrome.
    de Haan A; van der Gun I; Hepkema BG; de Boer WJ; van der Bij W; de Leij LF; Prop J
    Transplantation; 2000 Apr; 69(7):1434-9. PubMed ID: 10798767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cytotoxic T lymphocytes with destructive potential after cardiac valve homograft implantation.
    Oei FBS ; Welters MJ; Vaessen LM; Stegmann AP; Bogers AJ; Weimar W
    J Heart Valve Dis; 2000 Nov; 9(6):761-8. PubMed ID: 11128781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of donor-specific IL-2-secreting cells and cytotoxic T lymphocyte precursors in human kidney transplant recipients evidenced by limiting dilution analysis.
    Lantz O; Alard P; Ben Aribia MH; Chavanel G; Fries D; Senik A; Charpentier B
    J Immunol; 1990 May; 144(10):3748-55. PubMed ID: 2332630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tapering immunosuppression in recipients of living donor kidney transplants.
    Weimar W; Rischen-Vos J; de Kuiper P; Gregoor PJ; IJzermans JN; van Besouw NM; Baan CC; van der Mast BJ
    Nephrol Dial Transplant; 2004 Jul; 19 Suppl 4():iv61-3. PubMed ID: 15240852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of donor-specific CTL in a tolerant recipient of cardiac allograft.
    Petersson E; Qi Z; Hedlund G; Ekberg H
    Cell Immunol; 1998 Oct; 189(1):19-24. PubMed ID: 9758690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of donor-specific cytotoxic T lymphocyte precursors after transfusion.
    Vandekerckhove BA; van Bree S; Zhang L; Datema G; Zantvoort F; Claas FH
    Transplantation; 1989 Oct; 48(4):672-5. PubMed ID: 2799922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid decreases in donor-specific cytotoxic T lymphocyte precursor frequencies and graft outcome after liver and lung transplantation.
    de Haan A; van den Berg AP; van der Bij W; Hepkema BG; Bruin-van Dijk E; van der Gun I; Lems SP; Slooff MJ; Haagsma EB; de Leij LF; Prop J
    Transplantation; 2001 Mar; 71(6):785-91. PubMed ID: 11330543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients.
    Oei FB; Welters MJ; Knoop CJ; Vaessen LM; Stegmann AP; Weimar W; Bogers AJ
    Eur J Cardiothorac Surg; 2000 Oct; 18(4):466-72. PubMed ID: 11024386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD.
    de Bueger M; Bakker A; Bontkes H; van Rood JJ; Goulmy E
    Bone Marrow Transplant; 1993 May; 11(5):363-8. PubMed ID: 8504270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens.
    Angoulvant D; Clerc A; Benchalal S; Galambrun C; Farre A; Bertrand Y; Eljaafari A
    Biorheology; 2004; 41(3-4):469-76. PubMed ID: 15299278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-specific cytotoxic hyporesponsiveness associated with high interleukin-10 messenger RNA expression in cardiac allograft patients.
    Dijke IE; Velthuis JH; Balk AH; Korevaar SS; Maat AP; Weimar W; Baan CC
    J Heart Lung Transplant; 2006 Aug; 25(8):955-64. PubMed ID: 16890117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
    van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
    Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different patterns in donor-specific production of T-helper 1 and 2 cytokines by cells infiltrating the rejecting cardiac allograft.
    van Besouw NM; Daane CR; Vaessen LM; Balk AH; Claas FH; Zondervan PE; Jutte NH; Weimar W
    J Heart Lung Transplant; 1995; 14(5):816-23. PubMed ID: 8800715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.